Evercore Wealth Management, LLC Abb Vie Inc. Transaction History

Evercore Wealth Management, LLC

$6.66 Billion
Q3 2024

A detailed history of Evercore Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 88,185 shares of ABBV stock, worth $15.9 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

88,185

Previous 89,838 1.84%

Holding current value

$15.9 Million

Previous $15.4 Million 13.01%

% of portfolio

0.26%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $270,827 - $329,492	-1,653 Reduced 1.84%	88,185 $17.4 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $57,581 - $67,242	-372 Reduced 0.41%	89,838 $15.4 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $336,580 - $383,502	-2,106 Reduced 2.28%	90,210 $16.4 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $60,819 - $68,496	-442 Reduced 0.48%	92,316 $14.3 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $548,253 - $634,683	-4,104 Reduced 4.24%	92,758 $13.8 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $16,696 - $20,777	-126 Reduced 0.13%	96,862 $13.1 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $267,094 - $307,599	1,847 Added 1.94%	96,988 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $266,385 - $319,465	-1,926 Reduced 1.98%	95,141 $15.4 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $241,846 - $277,381	-1,802 Reduced 1.82%	97,067 $13 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $82,709 - $105,150	-601 Reduced 0.6%	98,869 $15.1 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $4,619 - $5,731	-35 Reduced 0.04%	99,470 $16.1 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $141,915 - $179,563	-1,321 Reduced 1.31%	99,505 $13.5 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $128,744 - $146,143	-1,210 Reduced 1.19%	100,826 $10.9 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $835,262 - $930,530	-7,939 Reduced 7.22%	102,036 $11.5 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $34,168 - $37,615	334 Added 0.3%	109,975 $11.9 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $50,064 - $67,592	622 Added 0.57%	109,641 $11.7 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $35,910 - $42,146	-418 Reduced 0.38%	109,019 $9.55 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $304,045 - $406,857	4,144 Added 3.94%	109,437 $10.7 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $86,430 - $131,038	1,340 Added 1.29%	105,293 $8.02 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $141,014 - $176,438	1,955 Added 1.92%	103,953 $9.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $156,064 - $187,634	-2,478 Reduced 2.37%	101,998 $7.72 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $842,208 - $1.08 Million	12,819 Added 13.99%	104,476 $7.6 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $478,730 - $563,442	6,206 Added 7.26%	91,657 $7.39 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $113,894 - $140,462	-1,463 Reduced 1.68%	85,451 $7.88 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $1 Million - $1.11 Million	-11,272 Reduced 11.48%	86,914 $8.22 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $63,294 - $74,892	705 Added 0.72%	98,186 $9.1 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $210,794 - $282,274	-2,291 Reduced 2.3%	97,481 $9.23 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $314,982 - $345,404	-3,517 Reduced 3.41%	99,772 $9.65 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $7.21 Million - $9.22 Million	103,289	103,289 $9.18 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.

Account

Evercore Wealth Management, LLC Abb Vie Inc. Transaction History